- Home
- GITS vs CVKD Comparison
GITS vs CVKD Comparison
Compare GITS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GITS | CVKD |
|---|---|---|
| Founded | 2018 | 2022 |
| Country | South Korea | United States |
| Employees | 12 | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 9.9M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GITS | CVKD |
|---|---|---|
| Price | $2.41 | $4.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 35.8K | ★ 42.3K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $4.21 |
| 52 Week High | $7.09 | $17.50 |
Technical Indicators
Market Signals| Indicator | GITS | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 39.00 |
| Support Level | $2.08 | $4.21 |
| Resistance Level | $2.40 | $14.21 |
| Average True Range (ATR) | 0.25 | 0.65 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 23.29 | 26.52 |
Price Performance
Historical ComparisonAbout GITS Global Interactive Technologies Inc.
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.